Novation, a healthcare industry supply contracting company, announces that NOVAPLUS® and Kimberly-Clark Health Care are hosting a sourcing event for products providers need in the event of a pandemic. The members of VHA, University HealthSystem Consortium (UHC) and Provista gain exclusive market value for pre-commitment of N95 respirators, standard masks and select gowns.
"With the flu season right around the corner, healthcare providers need to know that they have the products they need to effectively execute their pandemic preparedness plan," said Cathy Denning, Novation vice president. "This sourcing event with Kimberly-Clark will give the members we serve the confidence to know they have what they need when managing patients during this time."
The sourcing event is effective through Oct. 1 and all deliveries must take place by December 31, 2010. Participating members will receive a rebate equal to 3 percent of the total amount purchased through this sourcing event.
NOVAPLUS, Novations private label brand of pharmacy and medical-surgical products, delivers the best financial value for VHA, UHC and Provista members on the most frequently purchased commodity products. Originally founded in 1985 as VHAPLUS, the private label currently includes more than 1,100 products with annual purchases of $1.4 billion.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.